BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...abstracts as of Feb. 27. Target Indication Study type (s) Description Lead company or institution Adducin 3 (ADD3)...
BioCentury | Nov 20, 2014
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Amyotrophic lateral sclerosis (ALS) Adducin 1 (ADD1); ATPase Na+/K+ transporting a2 polypeptide (ATP1A2) In vitro and mouse studies suggest inhibiting ADD1 or ATP1A2 could help...
Items per page:
1 - 2 of 2